Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	67.15	53.38	31.94
Graham Fair Price	36.63	30356.84	22218.98
PEG	-53.84	0.03	0.06
Price/Book	14.73	0.27	0.24
Price/Cash Flow	98.89	0.88	-0.44
Prices/Earnings	-36.86	2.53	4.01
Price/Sales	-23.19	1.84	2.40
Price/FCF	98.89	0.88	-0.44
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	1.49	0.97	0.95
Operating Margin	-0.78	0.54	0.55
ROA	-24.28	< 0.005	< 0.005
ROE	0.01	0.03	81.72
ROIC	0.01	0.01	-20.37
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	1.49	0.78	90.27
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	2.99	0.50	-83.20
EPS QOQ	0.62	0.85	36.78
FCF QOQ	-1.51	1.58	5.12
Revenue QOQ	0.94	0.51	-45.13
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	115.51	1495.41	1194.60
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.65	0.82	26.32
Quick Ratio	0.55	0.77	40.06
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	38479.98	39000.47	1.35
Cash	33460.90	36299.64	8.48
Capex	-68.20	-10.00	85.34
Free Cash Flow	-20645.28	12070.89	-41.53
Revenue	3820.13	5783.24	51.39
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.66	50.04	80.94
Naive Interpretation	Member

06 - Financial Health · Bad

Rating